Anthera Pharmaceuticals, Inc. (ANTH)

Anthera Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Revenue	-	-	0.15	3.19	-	-
Revenue Growth (YoY)	-	-	-95.45%	-	-	-
Cost of Revenue	28.26	28.49	46.25	30.86	21.84	21.68
Gross Profit	-28.26	-28.49	-46.11	-27.68	-21.84	-21.68
Selling, General & Admin	8.54	7.94	11.07	7.57	6.62	6.56
Operating Expenses	8.54	7.94	11.07	7.57	6.62	6.56
Operating Income	-36.8	-36.43	-57.18	-35.24	-28.46	-28.25
Interest Expense	-	-	-	-	-1.05	-2.6
Currency Exchange Gain (Loss)	-	-	-	-	-	-0.02
Other Non Operating Income (Expenses)	13.41	10.16	1.65	0.02	-0.1	-
EBT Excluding Unusual Items	-23.39	-26.27	-55.52	-35.22	-29.6	-30.86
Other Unusual Items	-	-0.6	-	-	-	-
Pretax Income	-23.39	-26.87	-55.52	-35.22	-29.6	-30.86
Net Income	-23.39	-26.87	-55.52	-35.22	-29.6	-30.86
Preferred Dividends & Other Adjustments	1.54	2.5	10.91	-	-	-
Net Income to Common	-24.93	-29.38	-66.44	-35.22	-29.6	-30.86
Shares Outstanding (Basic)	14	10	5	4	3	2
Shares Outstanding (Diluted)	14	10	5	4	3	2
Shares Change (YoY)	152.23%	99.05%	15.94%	63.62%	19.21%	152.82%
EPS (Basic)	-1.76	-2.86	-12.87	-7.91	-10.88	-13.52
EPS (Diluted)	-1.76	-2.86	-12.87	-7.91	-10.88	-13.52
Free Cash Flow	-31.95	-36.9	-49.69	-30.99	-25.6	-31.93
Free Cash Flow Per Share	-2.26	-3.59	-9.62	-6.96	-9.40	-13.98
Operating Margin	-	-	-39432.41%	-1106.53%	-	-
Profit Margin	-	-	-45818.62%	-1105.81%	-	-
Free Cash Flow Margin	-	-	-34265.52%	-972.90%	-	-
EBITDA	-36.4	-36.15	-56.91	-34.96	-28.12	-27.89
D&A For EBITDA	0.4	0.28	0.27	0.29	0.34	0.35
EBIT	-36.8	-36.43	-57.18	-35.24	-28.46	-28.25
Revenue as Reported	-	-	0.15	3.19	-	-

Updated May 15, 2018. Source: S&P Global Market Intelligence. Standard template. Financial Sources.